Annex 2 is no longer applicable to Advanced Therapy Medicinal Products to which now applies the Commission guideline on Good Manufacturing Practice for Advanced Therapy Medicinal Products. The separate guideline on ATMPs is listed under Part IV of Eudralex Volume 4 and entered into force on 22 May 2018.
Source:
No comment has yet been written about this news
Write your comment about this news